Fertility recovery and pregnancy after allogeneic hematopoietic stem cell transplantation in Fanconi anemia patients

Abstract

Reduced fertility is one clinical manifestation among other well known Fanconi anemia features. Most recipients of allogeneic hematopoietic stem cell transplantation suffer from secondary infertility owing to gonadal damage from myeloablative conditioning. In order to evaluate the rate of pregnancy in Fanconi anemia transplanted patients, we performed a retrospective analysis of female patients transplanted in 15 centers from 1976 to 2008. Among 578 transplanted Fanconi anemia patients, we identified 285 transplanted females of whom 101 patients were aged 16 years or over. Ten became pregnant (4 twice). Before hematopoietic stem cell transplantation all had confirmed Fanconi anemia diagnosis. Median age at transplantation was 12 years (range 5-17 years). Conditioning regimen consisted of cyclophosphamide with or without irradiation. During follow up, 5 of 10 patients presented signs of ovarian failure. Among those, 2 patients spontaneously recovered regular menses, and 3 received hormonal replacement therapy. Pregnancy occurred from four to 17 years after hematopoietic stem cell transplantation. Three patients had preterm deliveries, one patient had a hysterectomy for bleeding. All 14 newborns had normal growth and development without congenital diseases. In conclusion, recovery of normal ovarian function and a viable pregnancy is a realistic but relatively rare possibility even in Fanconi anemia patients following hematopoietic stem cell transplantation. Mechanisms of fertility recovery are discussed

Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP)

“…Like similar analyses in other unique disease groups, 7 it is reassuring that most pregnancies were successful and that there were no reports of birth defects or long-term developmental problems. On the basis of adverse outcome in some autoimmune diseases, such as SSc, previous recommendations have included a high degree of caution and potentially discouragement for pregnancy.…”

The protective effects of human umbilical cord mesenchymal stem cells on damaged ovarian function: A comparative study

“…Given this contention, suitable stem cells could most likely be used to delay ovarian aging. Stem cell therapy has been found to restore the fertility of patients, although its mechanism is unclear (18). Mesenchymal stem cells (MSC) derived from Wharton's jelly of the human umbilical cord (human umbilical cord MSCs, or hUCMSCs) have displayed characteristics similar to those of bone marrow mesenchymal stromal cells (BMSCs).…”

How I treat MDS and AML in Fanconi anemia

“…73,74 Regarding fertility, viable pregnancy is rare but possible in FA patients before HSCT, as in patient 2, but also sometimes after transplant. 75 Back to our patients: staging, treatment, and FU Patient 1 This case illustrates a progressive clonal evolution in the BM, as shown by the serial acquisition of chromosomal translocations resulting in partial 1q duplication and partial 3q duplication 9 years later, both confirmed by FISH and aCGH. A sole chromosome 1q translocation or duplication can be seen in the early stages of BM clonal evolution in FA, including "normal" or hypoplastic BM, indicating that they are not associated per se with transformation.…”